Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Syngeneic Marek's Disease Virus (MDV)-Specific Cell-Mediated Immune Responses against Immediate Early, Late, and Unique MDV Proteins

1 Aug 1996

Abstract excerpt

Marek's disease (MD) infection has been controlled effectively by vaccination using nononcogenic and/or attenuated oncogenic Marek's disease virus (MDV) vaccines. Thus far, there is little knowledge on the role of cell-mediated immune (CMI) responses during MDV infection or vaccination. To elucidate the importance of MDV proteins in CMI responses, the pp38, Meq, ICP4, or ICP22 genes of an oncogenic strain, GA and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Herpesvirus Infections and Treatments
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8806490
DOI: 10.1006/viro.1996.0400

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Syngeneic Marek's Disease Virus (MDV)-Specific Cell-Mediated Immune Responses against Immediate Early, Late, and Unique MDV ProteinsPMID 8806490Read ↗

Characterization of Marek’s disease herpesvirus‐specific cytotoxic T lymphocytes in chickens inoculated with a non‐oncogenic vaccine strain of MDVSemantic proximity Read ↗

Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.Semantic proximity Read ↗

Biocharacteristics shared by highly protective vaccines against Marek's diseaseSemantic proximity Read ↗

A comprehensive screen for chicken proteins that interact with proteins unique to virulent strains of Marek's disease virus.Semantic proximity Read ↗

A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.Semantic proximity Read ↗

Difference in the meq Gene between Oncogenic and Attenuated Strains of Marek's Disease Virus Serotype 1.Semantic proximity Read ↗

Comparative susceptibility of Marek's disease cell lines to chicken infectious anemia virus.Semantic proximity Read ↗

Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses.Semantic proximity Read ↗

Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genesSemantic proximity Read ↗

A MEQ-Deleted Marek's Disease Virus Cloned as a Bacterial Artificial Chromosome Is a Highly Efficacious VaccineSemantic proximity Read ↗

MHC expression on spleen lymphocyte subsets in genetically resistant and susceptible chickens infected with Marek's disease virus.Semantic proximity Read ↗

Molecular Characterization of Major Histocompatibility Complex Class I (B‐F) mRNA Variants from Chickens Differing in Resistance to Marek's DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.